Researchers are developing advanced in vitro models of bladder cancer for preclinical testing, including the use of bladder cancer spheroids and hydrogel scaffolds. These models aim to improve understanding of the disease and facilitate the development of personalized therapies. Various studies are exploring different approaches, including the use of nanoplatforms, organoids, and epigenetic regulator delivery, to overcome therapeutic resistance and improve treatment outcomes.